The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Estradiol Transdermal System-Global Market Insights and Sales Trends 2025
Synopsis
Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
The global Estradiol Transdermal System market size is expected to reach US$ 463.4 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Estradiol Transdermal System in various end use industries. The expanding demands from the Hot Flashes, Prevention of Postmenopausal Osteoporosis, Treatment of Hypoestrogenism and Moderate-To-Severe Vasomotor Symptoms, are propelling Estradiol Transdermal System market. 0.025 mg per day, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 0.0375 mg per day segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Estradiol Transdermal System market, driven by demand from China, the second largest economy with some signs of stabilising, the Estradiol Transdermal System market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Estradiol Transdermal System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Estradiol Transdermal System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Estradiol Transdermal System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Estradiol Transdermal System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Estradiol Transdermal System covered in this report include Novartis, Allergan, Bayer, Noven Therapeutics, Mylan, Vertical Pharmaceuticals and Perrigo Pharma International, etc.
The global Estradiol Transdermal System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International
Global Estradiol Transdermal System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Estradiol Transdermal System market, Segment by Type:
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day
Global Estradiol Transdermal System market, by Application
Hot Flashes
Prevention of Postmenopausal Osteoporosis
Treatment of Hypoestrogenism
Moderate-To-Severe Vasomotor Symptoms
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Estradiol Transdermal System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Estradiol Transdermal System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
The global Estradiol Transdermal System market size is expected to reach US$ 463.4 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Estradiol Transdermal System in various end use industries. The expanding demands from the Hot Flashes, Prevention of Postmenopausal Osteoporosis, Treatment of Hypoestrogenism and Moderate-To-Severe Vasomotor Symptoms, are propelling Estradiol Transdermal System market. 0.025 mg per day, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 0.0375 mg per day segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Estradiol Transdermal System market, driven by demand from China, the second largest economy with some signs of stabilising, the Estradiol Transdermal System market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Estradiol Transdermal System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Estradiol Transdermal System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Estradiol Transdermal System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Estradiol Transdermal System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Estradiol Transdermal System covered in this report include Novartis, Allergan, Bayer, Noven Therapeutics, Mylan, Vertical Pharmaceuticals and Perrigo Pharma International, etc.
The global Estradiol Transdermal System market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International
Global Estradiol Transdermal System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Estradiol Transdermal System market, Segment by Type:
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day
Global Estradiol Transdermal System market, by Application
Hot Flashes
Prevention of Postmenopausal Osteoporosis
Treatment of Hypoestrogenism
Moderate-To-Severe Vasomotor Symptoms
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Estradiol Transdermal System manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Estradiol Transdermal System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Estradiol Transdermal System Market Overview
1.1 Estradiol Transdermal System Product Overview
1.2 Estradiol Transdermal System Market Segment by Type
1.2.1 0.025 mg per day
1.2.2 0.0375 mg per day
1.2.3 0.05 mg per day
1.2.4 0.075 mg per day
1.2.5 0.1 mg per day
1.3 Global Estradiol Transdermal System Market Size by Type
1.3.1 Global Estradiol Transdermal System Market Size Overview by Type (2018-2029)
1.3.2 Global Estradiol Transdermal System Historic Market Size Review by Type (2018-2023)
1.3.3 Global Estradiol Transdermal System Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Estradiol Transdermal System Sales Breakdown by Type (2018-2023)
1.4.2 Europe Estradiol Transdermal System Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Estradiol Transdermal System Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Estradiol Transdermal System Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Estradiol Transdermal System Sales Breakdown by Type (2018-2023)
2 Global Estradiol Transdermal System Market Competition by Company
2.1 Global Top Players by Estradiol Transdermal System Sales (2018-2023)
2.2 Global Top Players by Estradiol Transdermal System Revenue (2018-2023)
2.3 Global Top Players by Estradiol Transdermal System Price (2018-2023)
2.4 Global Top Manufacturers Estradiol Transdermal System Manufacturing Base Distribution, Sales Area, Product Type
2.5 Estradiol Transdermal System Market Competitive Situation and Trends
2.5.1 Estradiol Transdermal System Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Estradiol Transdermal System Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Estradiol Transdermal System as of 2022)
2.7 Date of Key Manufacturers Enter into Estradiol Transdermal System Market
2.8 Key Manufacturers Estradiol Transdermal System Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Estradiol Transdermal System Status and Outlook by Region
3.1 Global Estradiol Transdermal System Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Estradiol Transdermal System Historic Market Size by Region
3.2.1 Global Estradiol Transdermal System Sales in Volume by Region (2018-2023)
3.2.2 Global Estradiol Transdermal System Sales in Value by Region (2018-2023)
3.2.3 Global Estradiol Transdermal System Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Estradiol Transdermal System Forecasted Market Size by Region
3.3.1 Global Estradiol Transdermal System Sales in Volume by Region (2024-2029)
3.3.2 Global Estradiol Transdermal System Sales in Value by Region (2024-2029)
3.3.3 Global Estradiol Transdermal System Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Estradiol Transdermal System by Application
4.1 Estradiol Transdermal System Market Segment by Application
4.1.1 Hot Flashes
4.1.2 Prevention of Postmenopausal Osteoporosis
4.1.3 Treatment of Hypoestrogenism
4.1.4 Moderate-To-Severe Vasomotor Symptoms
4.1.5 Others
4.2 Global Estradiol Transdermal System Market Size by Application
4.2.1 Global Estradiol Transdermal System Market Size Overview by Application (2018-2029)
4.2.2 Global Estradiol Transdermal System Historic Market Size Review by Application (2018-2023)
4.2.3 Global Estradiol Transdermal System Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Estradiol Transdermal System Sales Breakdown by Application (2018-2023)
4.3.2 Europe Estradiol Transdermal System Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Estradiol Transdermal System Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Estradiol Transdermal System Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Estradiol Transdermal System Sales Breakdown by Application (2018-2023)
5 North America Estradiol Transdermal System by Country
5.1 North America Estradiol Transdermal System Historic Market Size by Country
5.1.1 North America Estradiol Transdermal System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Estradiol Transdermal System Sales in Volume by Country (2018-2023)
5.1.3 North America Estradiol Transdermal System Sales in Value by Country (2018-2023)
5.2 North America Estradiol Transdermal System Forecasted Market Size by Country
5.2.1 North America Estradiol Transdermal System Sales in Volume by Country (2024-2029)
5.2.2 North America Estradiol Transdermal System Sales in Value by Country (2024-2029)
6 Europe Estradiol Transdermal System by Country
6.1 Europe Estradiol Transdermal System Historic Market Size by Country
6.1.1 Europe Estradiol Transdermal System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Estradiol Transdermal System Sales in Volume by Country (2018-2023)
6.1.3 Europe Estradiol Transdermal System Sales in Value by Country (2018-2023)
6.2 Europe Estradiol Transdermal System Forecasted Market Size by Country
6.2.1 Europe Estradiol Transdermal System Sales in Volume by Country (2024-2029)
6.2.2 Europe Estradiol Transdermal System Sales in Value by Country (2024-2029)
7 Asia-Pacific Estradiol Transdermal System by Region
7.1 Asia-Pacific Estradiol Transdermal System Historic Market Size by Region
7.1.1 Asia-Pacific Estradiol Transdermal System Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Estradiol Transdermal System Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Estradiol Transdermal System Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Estradiol Transdermal System Forecasted Market Size by Region
7.2.1 Asia-Pacific Estradiol Transdermal System Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Estradiol Transdermal System Sales in Value by Region (2024-2029)
8 Latin America Estradiol Transdermal System by Country
8.1 Latin America Estradiol Transdermal System Historic Market Size by Country
8.1.1 Latin America Estradiol Transdermal System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Estradiol Transdermal System Sales in Volume by Country (2018-2023)
8.1.3 Latin America Estradiol Transdermal System Sales in Value by Country (2018-2023)
8.2 Latin America Estradiol Transdermal System Forecasted Market Size by Country
8.2.1 Latin America Estradiol Transdermal System Sales in Volume by Country (2024-2029)
8.2.2 Latin America Estradiol Transdermal System Sales in Value by Country (2024-2029)
9 Middle East and Africa Estradiol Transdermal System by Country
9.1 Middle East and Africa Estradiol Transdermal System Historic Market Size by Country
9.1.1 Middle East and Africa Estradiol Transdermal System Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Estradiol Transdermal System Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Estradiol Transdermal System Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Estradiol Transdermal System Forecasted Market Size by Country
9.2.1 Middle East and Africa Estradiol Transdermal System Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Estradiol Transdermal System Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Estradiol Transdermal System Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Estradiol Transdermal System Products Offered
10.1.5 Novartis Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Estradiol Transdermal System Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Allergan Estradiol Transdermal System Products Offered
10.2.5 Allergan Recent Development
10.3 Bayer
10.3.1 Bayer Company Information
10.3.2 Bayer Introduction and Business Overview
10.3.3 Bayer Estradiol Transdermal System Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bayer Estradiol Transdermal System Products Offered
10.3.5 Bayer Recent Development
10.4 Noven Therapeutics
10.4.1 Noven Therapeutics Company Information
10.4.2 Noven Therapeutics Introduction and Business Overview
10.4.3 Noven Therapeutics Estradiol Transdermal System Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Noven Therapeutics Estradiol Transdermal System Products Offered
10.4.5 Noven Therapeutics Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Estradiol Transdermal System Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Estradiol Transdermal System Products Offered
10.5.5 Mylan Recent Development
10.6 Vertical Pharmaceuticals
10.6.1 Vertical Pharmaceuticals Company Information
10.6.2 Vertical Pharmaceuticals Introduction and Business Overview
10.6.3 Vertical Pharmaceuticals Estradiol Transdermal System Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vertical Pharmaceuticals Estradiol Transdermal System Products Offered
10.6.5 Vertical Pharmaceuticals Recent Development
10.7 Perrigo Pharma International
10.7.1 Perrigo Pharma International Company Information
10.7.2 Perrigo Pharma International Introduction and Business Overview
10.7.3 Perrigo Pharma International Estradiol Transdermal System Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Perrigo Pharma International Estradiol Transdermal System Products Offered
10.7.5 Perrigo Pharma International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Estradiol Transdermal System Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Estradiol Transdermal System Industrial Chain Analysis
11.4 Estradiol Transdermal System Market Dynamics
11.4.1 Estradiol Transdermal System Industry Trends
11.4.2 Estradiol Transdermal System Market Drivers
11.4.3 Estradiol Transdermal System Market Challenges
11.4.4 Estradiol Transdermal System Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Estradiol Transdermal System Distributors
12.3 Estradiol Transdermal System Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
